hydroxyitraconazole has been researched along with Mycoses in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, JW; Joo, YD; Kang, HJ; Kim, H; Kim, HG; Kim, HY; Kim, JS; Kim, JY; Kim, SH; Kim, YK; Kim, YS; Lee, DG; Lee, JH; Min, YH; Mun, YC; Park, J; Ryoo, HM; Yi, HG | 1 |
| Abdel-Rahman, SM; Blumer, JL; Bradley, JS; Curtin, C; Jacobs, RF; Kauffman, RE; Kearns, GL; Kimko, HC; Maldonado, SD; Massarella, J; Shalayda, K | 1 |
| Danger, P; Lacroix, C; Wojciechowski, F | 1 |
| Bergmann, L; Böhme, A; Hoelzer, D; Just-Nübling, G; Shah, PM; Stille, W | 1 |
| Colardyn, F; De Beule, K; Decruyenaere, J; Groen, K; Jaqmin, P; Van Peer, A; Vandewoude, K; Vogelaers, D; Woestenborghs, R | 1 |
| Cornu, G; De Beule, K; de Repentigny, L; Jacqmin, P; Leclerc, JM; Ratelle, J; Sokal, EM | 1 |
2 trial(s) available for hydroxyitraconazole and Mycoses
| Article | Year |
|---|---|
Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies | 1996 |
Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adolescent; Adult; Antifungal Agents; beta-Cyclodextrins; Cyclodextrins; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Intensive Care Units; Itraconazole; Male; Middle Aged; Mycoses; Solutions | 1997 |
4 other study(ies) available for hydroxyitraconazole and Mycoses
| Article | Year |
|---|---|
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemotherapy-Induced Febrile Neutropenia; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Treatment Outcome; Young Adult | 2014 |
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adolescent; Antifungal Agents; beta-Cyclodextrins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Itraconazole; Male; Mycoses | 2007 |
Simultaneous determination of itraconazole, hydroxy-itraconazole and amphotericin B in human plasma by HPLC with photodiode array detection.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mycoses | 1995 |
Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
Topics: Administration, Oral; Antifungal Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Itraconazole; Male; Mycoses; Opportunistic Infections | 1998 |